Invention Grant
- Patent Title: Nicotinic acetylcholine receptor ligands 101
- Patent Title (中): 烟碱乙酰胆碱受体配体101
-
Application No.: US11749820Application Date: 2007-05-17
-
Publication No.: US07842803B2Publication Date: 2010-11-30
- Inventor: Hui-Fang Chang , Christopher Holmquist , Eifion Phillips , Timothy Piser , Thomas Simpson , Rebecca Urbanek , James Woods , Hui Xiong
- Applicant: Hui-Fang Chang , Christopher Holmquist , Eifion Phillips , Timothy Piser , Thomas Simpson , Rebecca Urbanek , James Woods , Hui Xiong
- Applicant Address: SE
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE
- Agency: Connolly Bove Lodge & Hutz, LLP
- Main IPC: C07D265/30
- IPC: C07D265/30 ; A61K31/5375
Abstract:
Nicotinic acetylcholine receptor ligands of Formula I wherein X, n, R1 and R2 are as described in the specification, diastereoisomers, enantiomers, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing, and methods for using the same.
Public/Granted literature
- US20080139600A1 Nicotinic Acetylcholine Receptor Ligands 101 Public/Granted day:2008-06-12
Information query
